# A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

> **NCT05708352** · PHASE2 · RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 170 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **BEHAVIORAL:** Keto Diet
- **BEHAVIORAL:** Standard Anti-Cancer Diet

## Key facts

- **NCT ID:** NCT05708352
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-27
- **Primary completion:** 2028-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05708352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05708352, "A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05708352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*